Expanding Surgical Frontiers Across the Pacific Ocean: Insights from the First Telesurgery Procedures Connecting Orlando with Shanghai in Animal Models.
Vipul Patel, Mischa Dohler, Jacques Marescaux...
https://pubmed.ncbi.nlm.nih.gov/39502103/Actively Recruiting
Led by AdventHealth · Updated on 2026-10-08
10
Participants Needed
1
Research Sites
252 weeks
Total Duration
Researchers are evaluating the safety and effectiveness of robotic telesurgery for prostate diseases, including localized prostate cancer and benign prostate conditions. This study focuses on how well telesurgery works in real hospital settings, addressing technical challenges like internet speed and delays, and exploring its use in training new surgeons. The study is sponsored by AdventHealth and aims to advance humanitarian healthcare using this innovative technology. Participants will undergo robotic telesurgery performed remotely by highly trained surgeons using the Microport Medbot Robotic Platform. The surgery involves a secure internet connection to operate on patients who require robotic urologic surgery but lack access to this technology in their routine care. The study includes patients needing robotic radical prostatectomy or simple prostatectomy based on their diagnosis. This is a single-group interventional study assessing telesurgery feasibility and safety during surgical procedures lasting approximately 90 minutes. During the study, participants will be closely monitored from the start to the end of their surgical procedure. Researchers will measure the duration and technical stability of the telesurgery connection and assess safety and feasibility throughout the operation. Participants must be mentally capable of understanding the study and willing to follow perioperative and follow-up schedules. The total participation duration aligns with the surgical procedure and follow-up requirements, with safety monitored during and after surgery.
CONDITIONS
Exploring the Potential of Robotic Telesurgery in Remote Settings
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
AdventHealth
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Remote Robotic Telesurgery | In-Person Robotic Prostatectomy |
|---|---|---|
| What it is | Robotic prostatectomy or simple prostatectomy performed remotely by an expert surgeon using the Microport Medbot system, with the surgeon operating via a secure internet link from a distant location. | Robot-assisted radical or simple prostatectomy performed entirely onsite, with the surgeon present in the same hospital as the patient and directly controlling the robotic surgical platform. |
| Role in the study | Investigational intervention. All enrolled participants receive telesurgery as the studied method. | Current standard of care for appropriate prostate conditions. Not part of the trial but widely used outside the study. |
| Primary use | Performed for patients with localized prostate cancer needing radical prostatectomy or benign prostate disease needing simple prostatectomy, especially those without local access to in-person robotic surgery. | First-line or gold-standard surgical management for patients with localized prostate cancer or symptomatic benign prostatic hyperplasia when robotic surgery is available onsite. |
| How it is given or performed | The surgeon operates the robot from a remote location through a secure Internet connection, with visual and instrument control feedback. Surgery takes place at a hospital equipped with the robotic platform; the patient is under anesthesia on site. | The surgeon is present in the same hospital as the patient and directly operates the robotic surgical system via local consoles, with the patient under anesthesia in an operating room. |
| Evidence status | Ongoing early clinical investigation. This trial and published literature suggest feasibility, but large-scale patient outcome data remain limited. | Extensive long-term and high-quality evidence demonstrate safety, efficacy, and outcomes for both radical and simple prostatectomy among appropriate patients. |
| Important limitations | Telesurgery requires advanced network infrastructure with low latency and backup connectivity. Most published cases focus on technical feasibility, and data on long-term outcomes or complication rates compared to in-person surgery are not yet established. | Restricted to patients with access to hospitals that offer robotic surgery. Requires specialist teams and equipment; not universally available in all regions. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Approximately 90 minutes
Participants undergo robotic telesurgery performed remotely by a trained surgeon using a secure internet connection.
1 surgical procedure visit
Duration - Duration varies per participant
Participants are monitored for safety and feasibility from the start through the completion of the surgical procedure and during post-operative care.
Visits as scheduled for follow-up care
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Vipul Patel, Mischa Dohler, Jacques Marescaux...
https://pubmed.ncbi.nlm.nih.gov/39502103/Vipul Patel, Marcio Covas Moschovas, Jacques Marescaux...
https://pubmed.ncbi.nlm.nih.gov/38819496/Vipul Patel, Jacques Marescaux, Marcio Covas Moschovas
https://pubmed.ncbi.nlm.nih.gov/38762391/Marcio Covas Moschovas, Shady Saikali, Mischa Dohler...
https://pubmed.ncbi.nlm.nih.gov/39556854/Mischa Dohler, Shady Saikali, Ahmed Gamal...
https://pubmed.ncbi.nlm.nih.gov/39549181/Bernardo Rocco, Marcio Covas Moschovas, Shady Saikali...
https://pubmed.ncbi.nlm.nih.gov/38833111/Sumeet Kumar Reddy, Shady Saikali, Ahmed Gamal...
https://pubmed.ncbi.nlm.nih.gov/39435556/AdventHealth
Lead Sponsor